Folinoral
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
1239 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Colorectal neoplasms | D015179 | — | — | 81 | 250 | 140 | 4 | 19 | 453 |
| Rectal neoplasms | D012004 | — | — | 39 | 91 | 47 | 1 | 5 | 171 |
| Colonic neoplasms | D003110 | — | C18 | 39 | 76 | 57 | 1 | 7 | 162 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 53 | 90 | 33 | 1 | 7 | 160 |
| Adenocarcinoma | D000230 | — | — | 21 | 74 | 20 | 1 | 6 | 111 |
| Stomach neoplasms | D013274 | EFO_0003897 | C16 | 24 | 63 | 19 | 1 | 5 | 101 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | 17 | 39 | 15 | 1 | 4 | 71 |
| Esophageal neoplasms | D004938 | — | C15 | 15 | 36 | 4 | 1 | 2 | 49 |
| Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 7 | 18 | 9 | 1 | 4 | 36 |
| Cholangiocarcinoma | D018281 | — | C22.1 | 4 | 16 | 2 | 1 | — | 22 |
Show 9 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neoplasms | D009369 | — | C80 | 63 | 64 | 25 | — | 4 | 140 |
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 14 | 33 | 24 | — | 3 | 67 |
| Lymphoma | D008223 | — | C85.9 | 8 | 37 | 14 | — | 6 | 59 |
| Carcinoma | D002277 | — | C80.0 | 8 | 27 | 14 | — | 4 | 48 |
| Leukemia | D007938 | — | C95 | 4 | 28 | 16 | — | 2 | 47 |
| Pancreatic ductal carcinoma | D021441 | — | — | 15 | 19 | 5 | — | 1 | 35 |
| Hepatocellular carcinoma | D006528 | — | C22.0 | 7 | 18 | 8 | — | 2 | 32 |
| Burkitt lymphoma | D002051 | — | C83.7 | 5 | 15 | 8 | — | — | 27 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 7 | 9 | 7 | — | 2 | 24 |
| Hiv infections | D015658 | EFO_0000764 | B20 | 5 | 2 | 8 | — | 9 | 24 |
Show 104 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Myeloid leukemia acute | D015470 | — | C92.0 | 9 | 3 | — | — | — | 11 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 5 | 6 | — | — | — | 11 |
| Myelodysplastic syndromes | D009190 | — | D46 | 8 | 3 | — | — | — | 10 |
| Mantle-cell lymphoma | D020522 | — | C83.1 | 3 | 7 | — | — | — | 10 |
| Hodgkin disease | D006689 | — | C81 | 6 | 4 | — | — | — | 9 |
| Sarcoma | D012509 | — | — | 3 | 6 | — | — | — | 9 |
| Osteosarcoma | D012516 | — | — | 3 | 5 | — | — | 1 | 8 |
| B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 4 | 3 | — | — | — | 7 |
| Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | 2 | 6 | — | — | — | 7 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 2 | 4 | — | — | — | 6 |
Show 114 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Gastrointestinal stromal tumors | D046152 | EFO_0000505 | C49.A | 4 | — | — | — | — | 4 |
| Immunoblastic lymphadenopathy | D007119 | EFO_1001350 | C86.5 | 2 | — | — | — | 1 | 3 |
| Diarrhea | D003967 | — | R19.7 | 1 | — | — | — | 1 | 2 |
| Sezary syndrome | D012751 | — | C84.1 | 1 | — | — | — | 1 | 2 |
| T-cell lymphoma cutaneous | D016410 | — | C84.A | 1 | — | — | — | 1 | 2 |
| Pseudomyxoma peritonei | D011553 | EFO_0007456 | — | 1 | — | — | — | 1 | 2 |
| Prostatic neoplasms | D011471 | — | C61 | 1 | — | — | — | — | 1 |
| Anemia | D000740 | EFO_0004272 | D64.9 | 1 | — | — | — | — | 1 |
| Thrombocytosis | D013922 | — | D75.83 | 1 | — | — | — | — | 1 |
| Skin neoplasms | D012878 | EFO_0004198 | C44 | 1 | — | — | — | — | 1 |
Show 24 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Aggression | D000374 | EFO_0003015 | — | — | — | — | — | 1 | 1 |
| Invasive hydatidiform mole | D002820 | — | D39.2 | — | — | — | — | 1 | 1 |
| Juvenile arthritis | D001171 | EFO_1002007 | M08 | — | — | — | — | 1 | 1 |
| Behavior | D001519 | GO_0007610 | STY/T053 | — | — | — | — | 1 | 1 |
| Microbiota | D064307 | — | — | — | — | — | — | 1 | 1 |
| Healthy diet | D000072001 | — | — | — | — | — | — | 1 | 1 |
| Ultrasonic therapy | D014464 | — | — | — | — | — | — | 1 | 1 |
| Multiple primary neoplasms | D009378 | — | — | — | — | — | — | 1 | 1 |
| Overweight | D050177 | — | E66.3 | — | — | — | — | 1 | 1 |
| Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | — | — | — | 1 | 1 |
Show 4 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
88 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use